Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS).

Sathyapalan, Thozhukat

Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS). [electronic resource] - Clinical endocrinology Jan 2009 - 124-8 p. digital

Publication Type: Controlled Clinical Trial; Journal Article

1365-2265

10.1111/j.1365-2265.2008.03345.x doi


Adult
Androgens--blood
Female
Humans
Insulin Resistance
Metformin--therapeutic use
Piperidines--therapeutic use
Polycystic Ovary Syndrome--drug therapy
Pyrazoles--therapeutic use
Rimonabant
Testosterone--blood
Weight Loss--drug effects